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sing ﬂuorescent variants of Fas and FasL, we show
that membrane FasL and Fas form supramolecular
clusters that are of ﬂexible shape, but nevertheless
stable and persistent. Membrane FasL-induced Fas clus-
ters were formed in caspase-8– or FADD-deﬁcient cells or
when a cytoplasmic deletion mutant of Fas was used sug-
gesting that cluster formation is independent of the as-
sembly of the cytoplasmic Fas signaling complex and
downstream activated signaling pathways. In contrast,
cross-linked soluble FasL failed to aggregate the cytoplas-
mic deletion mutant of Fas, but still induced aggregation
U
 
of signaling competent full-length Fas. Moreover, mem-
brane FasL-induced Fas cluster formation occurred in the
presence of the lipid raft destabilizing component methyl-
 
 
 
-cyclodextrin, whereas Fas aggregation by soluble FasL
was blocked. Together, these data suggest that the extra-
cellular domains of Fas and FasL alone are sufﬁcient to
drive membrane FasL-induced formation of supramolecular
Fas–FasL complexes, whereas soluble FasL-induced Fas
aggregation is dependent on lipid rafts and mechanisms
associated with the intracellular domain of Fas.
 
Introduction
 
Fas (Apo-1/CD95) is the prototypic member of the death re-
ceptor subgroup of the TNF receptor family. In vivo, Fas is
activated by membrane FasL and induces apoptosis in a variety
of cells under crucial involvement of its COOH-terminal death
domain. The death domain is a protein–protein interaction
module found in several apoptosis-related proteins involved
in death receptor signaling (Fesik, 2000) and mediates both
induction of apoptosis and nonapoptotic signaling pathways
(Wajant et al., 2003; Kreuz et al., 2004). At the cell surface Fas
forms noncovalently preassembled complexes in which by yet
unknown mechanisms the Fas death domains are hindered from
interaction with death domain-containing intracellular adaptor
proteins (Siegel et al., 2000). Besides membrane FasL, Fas can
also be activated by agonistic antibodies or secondarily aggre-
gated soluble FasL. In contrast, native soluble FasL, a pro-
cessed version of membrane FasL, does normally not activate
Fas (Suda et al., 1997; Schneider et al., 1998).
Formation of signaling competent Fas complexes is
accompanied by recruitment of the cytoplasmic death do-
main-containing adaptor protein Fas-associated death domain
(FADD; Peter and Krammer, 2003). FADD recruitment de-
pends on the interaction between the death domains of Fas and
FADD. Fas-bound FADD in turn is able to bind procaspase-8.
Within this death-inducing signaling complex (DISC), pro-
caspase-8 is activated by dimerization (Boatright et al., 2003;
Donepudi et al., 2003). DISC-bound active procaspase-8 dimers
are then converted by autoproteolytic processing into the ma-
ture and active heterotetrameric form of the enzyme which is
released from the Fas signaling complex. Active caspase-8
cleaves a limited set of substrates including caspase-3 and the
BH3-only protein Bid. Two types of cells can be defined. In
type I cells caspase-8 mediated activation of caspase-3 is suffi-
cient to ensure execution of the final steps of apoptosis (Barn-
hart et al., 2003; Peter and Krammer, 2003). In contrast, in type
II cells caspase-8 activation is less efficient and/or activation of
effector caspases is inhibited by members of the inhibitor of
apoptosis (IAP) protein family (Barnhart et al., 2003; Peter and
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Krammer, 2003). In these cells, a caspase-8 generated cleavage
product of Bid, named truncated Bid, may contribute to apopto-
sis by inducing Bax/Bak-dependent release of apoptogenic pro-
teins from mitochondria, especially cytochrome 
 
c
 
 and further
SMAC/Diablo and HtrA2/Omi (Barnhart et al., 2003; Peter and
Krammer, 2003). Cytochrome 
 
c
 
 assembles in the cytoplasm
with ATP and the scaffold protein apoptosis promoting factor-1
to form the caspase-9 activating apoptosome (Shi, 2002), which
in turn processes and activates caspase-3. Smac/Diablo and
HtrA2/Omi block caspase inhibition by members of the IAP
protein family (Verhagen and Vaux, 2002). Thus, both mecha-
nisms enhance the effect of initially DISC-activated caspase-8
and facilitate activation of effector caspases, especially caspase-3.
A contribution of the mitochondrial pathway to Fas-induced
apoptosis has been experimentally defined in vitro by ectopic
overexpression of the anti-apoptotic Bcl2 protein (Scaffidi et
al., 1998). In type I cells, Fas-induced apoptosis is not affected
by the Bcl2-dependent inhibition of Bax/Bak-mediated release
of apoptogenic factors. In contrast, in type II cells Bcl2 expres-
sion attenuates apoptosis induction by Fas (Barnhart et al.,
2003; Peter and Krammer, 2003). In vivo, thymocytes have
consistently been recognized as type I cells. Although some in
vivo studies using suboptimal doses of agonistic anti-Fas anti-
bodies found a contribution of the mitochondrial pathway in
Fas-induced apoptosis of hepatocytes, the conclusions regard-
ing the in vivo relevance of the mitochondrial pathway for Fas-
induced apoptosis extracted from these data are discussed dif-
ferently (Schmitz et al., 1999; Huang et al., 2000).
Although Fas signaling is well understood, the mecha-
nisms that drive the formation of signaling competent Fas com-
Figure 1. Membrane FasL and Fas form supramolecular
clusters. (A) Scheme of YFP and CFP fusion proteins of
Fas and FasL. (B) HeLa cells were transfected with expres-
sion plasmids encoding YFP-FasL or CFP-FasL and Fas-YFP
or with a mixture of the latter two plasmids in the pres-
ence of z-VAD-fmk (20  M). Images shown were taken
after 24 h and are representative for each experimental
group. (C) HeLa cells transfected with CFP-FasL and Fas-
YFP, respectively, were harvested 24 h after transfection,
mixed at a 1:1 ratio, and cocultured for additional 24 h.
Images shown are representative for neighboring cells ex-
pressing CFP-FasL and Fas-YFP, respectively. (D) HeLa
cells were separately transfected with plasmids encoding
the indicated proteins and cocultured overnight. After 24 h,
at least 100 yellow fluorescent cells that neighbored
one or more blue fluorescent cells were selected on ran-
domly chosen sections of the slide and analyzed for clus-
ter formation. The portions of cells that displayed ligand
receptor clusters were determined. (E) HeLa cells were
transfected with CFP-FasL and were cocultured 24 h after
transfection with SKW cells in the presence of 20  M
z-VAD-fmk for 3 h. Cells were fixed and stained with anti-
Fas and a CY5-labeled secondary antibody. 
MEMBRANE FASL-INDUCED FAS CLUSTERING • HENKLER ET AL.
 
1089
 
plexes are poorly defined. Soluble trimeric FasL interacts with
three molecules of Fas but fails to activate the receptor effi-
ciently. In contrast, hexameric soluble FasL or antibody cross-
linked soluble FasL are sufficient to induce Fas signaling
(Schneider et al., 1998; Holler et al., 2003). Therefore, it has
been suggested that Fas activation requires secondary interaction
of trimeric FasL–Fas (FasL
 
3
 
–Fas
 
3
 
) complexes. This concept is
also in agreement with the observation that agonistic Fas specific
antibodies belong to the IgM or IgG3 subclass or require second-
ary aggregation e.g., by protein A (Kischkel et al., 1995; Huang
et al., 1999). Treatment of Fas expressing cells with cross-linked
FasL or agonistic anti-Fas antibodies induces higher order clus-
ters (“capping”), which are detectable by immunofluorescent mi-
croscopy (von Reyher et al., 1998; Cremesti et al., 2001; Grassme
et al., 2001a,b; Algeciras-Schimnich et al., 2002). Although the
Fas DISC is rapidly assembled, several lines of evidence suggest
that formation of this procaspase-8 converting protein complex is
not the first consequence of Fas stimulation but rather a later step
in the conversion of preassembled signaling incompetent Fas
complexes into “activated” receptor complexes (Grassme et al.,
2001a,b; Cremesti et al., 2001; Algeciras-Schimnich et al., 2002).
In particular, formation of Fas microclusters (Kischkel et al.,
1995; Kamitani et al., 1997; Ruiz-Ruiz et al., 1999; Varadha-
chary et al., 2001; Algeciras-Schimnich et al., 2002), actin reor-
ganization (Algeciras-Schimnich et al., 2002), inducible or
constitutive association with membrane rafts (Grassme et al.,
2001a,b; Hueber et al., 2002; Aouad et al., 2004, Muppidi and
Siegel, 2004) and acid sphingomyelinase mediated ceramide pro-
duction (Cremesti et al., 2001) have been discussed as important
intermediate steps preceding robust DISC formation.
Here, we show that membrane FasL and Fas form su-
pramolecular clusters of high stability, persisting for several
hours. In contrast to early, soluble FasL-induced Fas aggre-
gates, recently named signaling protein oligomeric transduc-
tion structures (SPOTS), membrane FasL-induced Fas clusters
form independently of the intracellular domain of Fas and oc-
cur in the absence of FADD or caspase-8 suggesting that the
formation of supramolecular FasL-Fas clusters precedes and is
independent of recruitment and activation of downstream
signaling components.
 
Results
 
Supramolecular FasL-Fas clusters are 
durable and highly stable
 
The mechanisms leading to Fas clustering and Fas activation
have been predominantly analyzed with cross-linked variants of
soluble trimeric FasL or agonistic Fas-specific antibodies. How-
ever, the prime in vivo activator of Fas is the transmembrane
form of FasL. To analyze membrane FasL-induced Fas cluster-
ing in living cells by confocal microscopy we have used YFP
and CFP fusion proteins of FasL and Fas (Fig. 1 A). Analysis
of apoptosis induction, IL8 up-regulation and NF
 
 
 
B activation
showed that the various YFP and CFP fusion proteins were
functional with respect to apoptotic and nonapoptotic Fas signal-
ing (Fig. S1, available at http://www.jcb.org/cgi/content/full/
jcb.200501048/DC1). The confocal images of HeLa cells indi-
vidually transfected with either CFP-FasL or Fas-YFP in Fig. 1 B
show the typical membrane expression pattern of these fusion
proteins. As expected, both proteins appear as proteins enriched
at the plasma membrane and at intracellular membranes and ves-
icles, en route to the cell membrane. Although Fas-YFP was
Figure 2. Supramolecular FasL-Fas clusters are highly stable durable
structures. HeLa cells were transfected with CFP-FasL and Fas-YFP, respec-
tively, and were cocultured in the presence of 20  M z-VAD-fmk. The next
day, 25  g/ml CHX were added and after an additional hour a representa-
tive pair of transfected cells was analyzed by life imaging fluorescence mi-
croscopy. After the indicated times images were taken. (B, left) HeLa cells
overexpressing Fas were pretreated with CHX (25  g/ml) for 30 min and
were then challenged with 400 ng/ml of M2-cross-linked Flag-FasL on ice or
at 37 C. After 1 h Fas cell surface expression was determined by FACS
analysis. The experiment was done in triplicates. (B, right) HeLa cells trans-
fected with Fas-YFP or CFP-FasL were cocultivated. Cells were then pre-
treated with CHX and fluorescence intensities of nine Fas-YFP expressing
cells forming FasL-Fas clusters with neighboring CFP-FasL cells were de-
termined for a 2-h interval by confocal microscopy. (C) HeLa cells were
transfected with an expression plasmid encoding Fas-YFP and cultured
without z-VAD-fmk. The next day, cells were challenged with a suspension
of freshly harvested HEK293 cells, expressing CFP-FasL. Imaging was
started when first FasL-Fas clusters became apparent (arrows) and followed
until the dying Fas-YFP expressing cell detached from the plastic surface. 
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found to be homogeneously distributed in the plasma membrane,
YFP-FasL (Fig. 1 B) and CFP-FasL (not depicted) showed a
speckled distribution. Notably, the detection pattern of FasL did
not depend on the individual expression levels of analyzed cells.
It is possible that FasL has an intrinsic tendency to form micro-
scopically distinct aggregates. It cannot be formally ruled out
that these small aggregates occur partly due to clustering with
endogenous Fas. However, the same speckled appearance of
YFP-FasL was also observed in cells expressing high amounts
of the FasL fusion protein, thus in cells, where the expression
level of YFP-FasL is many fold higher than that of endogenous
Fas. When CFP-FasL and Fas-YFP were coexpressed in the
same cell, both molecules did efficiently colocalize in patches,
demonstrating that FasL and Fas can also interact on the same
cell (unpublished data). In contrast, patching did not occur when
CFP-FasL was cotransfected with CD40-YFP. In coculture as-
says of cells separately transfected with CFP-FasL and Fas-YFP
(or YFP-FasL and Fas-CFP) FasL-Fas clustering between neigh-
boring cells was found with very high incidence (Fig. 1, C and
D). There were no effects on the distribution of CFP-FasL and
YFP-Fas when these transfectants were cocultured with CD40-
YFP and CFP-CD40L transfected cells, respectively (unpub-
lished data). FasL-Fas clusters at sites of cell-to-cell contacts
were formed when Fas-YFP was in type I (SV80, SKW) or type
II cells (HeLa, Jurkat), as well as after expression in adherent
(SV80, HeLa) and suspended cells (Jurkat, SKW) suggesting
that the capability of membrane FasL to induce Fas clustering is
not a cell-type specific property (unpublished data). Further-
more, in SKW cells, endogenously expressed Fas molecules
were also efficiently incorporated in clusters when the cells were
Figure 3. FLIP analysis of free and clustered YFP-FasL and Fas-YFP. HeLa cells transfected with YFP-FasL and Fas-YFP, respectively, were cultured individually
or together with HeLa cells expressing CFP fusion proteins of the corresponding receptor or ligand. Images of a representative cell from each experimental
group are shown. Bleaching areas covering most of the cell except the analyzed FasL-Fas cluster and/or a control region in the plasma membrane were
defined (dotted lines). Cells were initially bleached for 5 min to bleach the majority of the highly diffusible intracellular fraction of the YFP fusion proteins.
After this, bleaching was continued, and images were recorded in 1-min intervals. Using these images, loss of fluorescence in nonbleached areas, which
contained clusters or control membrane, was determined, as described in Materials and methods. These areas were defined as ROI, and are indicated
(dotted line, bleach area; solid line, ROI of clustered or free YFP fusion protein; dashed line, control ROI). Measurements of clustered YFP fusion proteins
(Fas-YFP, closed squares top diagram; YFP-FasL, closed squares bottom diagram) were corrected for each time point for the residual fluorescence of the
corresponding “free” protein outside the bleach region. Fluorescence intensities of nonclustered Fas-YFP (open squares top diagram) and YFP-FasL (open
squares bottom diagram) determined outside the bleach regions were corrected for the rest fluorescence within the bleach region. Corrected fluorescence
intensities were normalized against the relative fluorescence intensity obtained after the initial five bleach cycles. This time point of each experiment was
defined as t   0 min. Averaged (n   12–15) normalized relative fluorescence intensities were shown in the diagrams. The fluorescence loss indicating
dissociation was linearized by plotting the natural logarithm of the relative fluorescence intensities over time. The third row in the top part shows a control
experiment where besides Fas-YFP membrane CFP were coexpressed to demonstrate that the overall morphology of bleached cells was not affected. 
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cocultured with CFP-FasL expressing cells (Fig. 1 E). Form and
size of FasL-Fas clusters between neighboring cells were highly
variable. Small “contact plates”, bigger dot-like clusters, and
larger membrane stretches of Fas-FasL positive cell–cell con-
tacts were regularly observed. As the majority of the fusion
proteins were frequently trapped almost completely within su-
pramolecular FasL-Fas clusters, overall cellular morphology
was always ascertained by light microscopy. To prevent induc-
tion of apoptosis, FasL-Fas clustering was analyzed in the pres-
ence of the pan-caspase inhibitor z-VAD-fmk. This indicates
that caspase-8 activation is not necessary for cluster formation.
In z-VAD-fmk protected cells time-lapse microscopy re-
vealed that the FasL-Fas clusters, although undergoing slow dy-
namic morphologic changes, are stable over hours even in the
presence of high concentrations of cycloheximide (25 
 
 
 
g/ml),
thus under conditions were synthesis of new proteins was com-
pletely inhibited (Fig. 2, A and B). This indicated that under con-
ditions of Fas activation, there was no or only a very limited in-
ternalization, an interesting difference to what has been reported
for Fas stimulation with soluble reagents (Algeciras-Schimnich
et al., 2002; Eramo et al., 2004). To verify whether soluble FasL
is capable to induce changes in Fas cell surface expression in the
cellular system used here, we comparatively analyzed cell sur-
face expression of soluble FasL-stimulated and nonstimulated
Fas transfected HeLa cells. In accordance with soluble FasL-
induced internalization, Fas cell surface expression was lowered
in the FasL-treated cells by 20–30% 2 h after stimulation (Fig. 2
B). The extent of reduction in Fas cell surface expression was
comparable to that observed in the cited studies. To analyze the
relationship of cluster formation and apoptosis induction, freshly
harvested CFP-FasL expressing cells were added to adherent
Fas-YFP transfected cells and cluster formation was monitored
online when first signs of cell to cell contact were obvious.
Within 1–4 h after initial cluster formation the majority of cy-
cloheximide sensitized (not depicted) as well as a significant
portion of nonsensitized (Fig. 2 C) Fas-YFP expressing cells
rounded up and detached from the tissue culture plates indicating
apoptosis of Fas-YFP expressing cells. Notably, clusters be-
tween CFP-FasL expressing cells and dying Fas-YFP transfec-
tants remained stable and intact till detachment and even longer.
To analyze the stability of the FasL-Fas clusters further,
we determined the exchange of unbound and cluster-bound mol-
ecules of YFP-FasL and Fas-YFP. We selected transfected cells
with moderate YFP fusion protein levels and measured the loss
of fluorescence in the FasL-Fas clusters or in plasma membrane
areas of comparable size while continuously bleaching the YFP
fusion protein in the remaining area of transfected cells (Fig. 3).
This revealed a clear difference of fluorescence loss between
“free” and clustered fusion proteins. In case of nonclustered
YFP-FasL and Fas-YFP, half of the fluorescence was lost in 7.2
and 3.5 min, respectively. Thus, free membrane Fas exerts a sig-
nificantly higher mobility than nonclustered FasL. However,
when YFP-FasL and Fas-YFP were localized in clusters, loss of
fluorescence was comparable for both molecules, but strongly
reduced, as compared with their nonclustered counterparts. De-
cay of fluorescence of the clustered proteins was 
 
 
 
15% within
15 min. Based on the assumption that the fluorescence of the
clustered fusion proteins declines with exponential kinetics the
average retention periods were 
 
 
 
72 and 59 min.
 
The extracellular domains of FasL and 
Fas are sufficient for the formation of 
supramolecular clusters
 
The fact that the caspase inhibitor z-VAD-fmk does not interfere
with the formation of FasL-Fas clusters in our experiments ar-
gues against a crucial role of caspase-8 in FasL-induced Fas ag-
gregation. As studies with soluble Fas agonists have reported
such a role we further substantiate this finding by analyzing Fas
cluster formation in Jurkat clones deficient in the expression of
FADD or caspase-8 after cocultivation with CFP-FasL express-
ing HeLa cells. Jurkat cells were only transfected with low effi-
ciency (0.5 – 3%). Accordingly, there was only a low number
(20–50) of neighboring cell pairs that expressed Fas-YFP and
CFP-FasL, respectively. However, clusters were observed in the
Figure 4. The cytoplasmic domains of Fas
and FasL and caspase-8 and FADD are dis-
pensable for cluster formation. Parental Jurkat
cells and derived clones deficient in FADD or
caspase-8 expression were electroporated
with Fas-YFP. After 1 d of recovery trans-
fected Jurkat cells were cocultured with CFP-
FasL transfected HeLa cells in the presence of
20  M z-VAD-fmk. After 3 h Fas-YFP express-
ing Jurkat cells that overlaid or neighbored
CFP-FasL expressing HeLa cells were ana-
lyzed for occurrence of FasL-Fas clusters. Total
numbers and percentage of cluster positive
cell pairs are indicated for one representative
experiment. Pictures show examples of iso-
lated Fas-YFP expressing Jurkat cells and Jurkat-
HeLa cell pairs having Fas-YFP CFP-FasL
clusters (arrows). 
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vast majority of such cell pairs, indicating that this process is in-
dependent from FADD or caspase-8 (Fig. 4). To exclude a con-
tribution of other Fas interacting signaling components in cluster
formation, we analyzed the capacity of a Fas deletion mutant
lacking the entire cytoplasmic domain (Fas
 
 
 
cyt) to form clus-
ters (Fig. 5 A). As in case of the Fas-related CD40-CD40L sys-
tem, a reverse signaling activity of the ligand has been impli-
cated in the formation of supramolecular clusters (Grassme et
al., 2002), we also analyzed deletion mutants of FasL lacking the
cytoplasmic domain. Although the Fas
 
 
 
cyt mutants were unable
to activate the signaling pathways that are associated with
Fas and act as dominant-negative variants, the FasL deletion mu-
tants were comparably active as the wild-type ligand (Fig. S2,
available at http://www.jcb.org/cgi/content/full/jcb.200501048/
DC1). In HeLa cells, which has been transfected with Fas-YFP
or Fas
 
 
 
cyt-YFP, cluster induction was initiated by overlaying
FasL-CFP expressing 293 cells. After 1 h coculture near to
100% cluster incidence was observed in Fas-YFP as well as in
Fas
 
 
 
cyt-YFP expressing cells that were in contact with CFP-
FasL expressing cells (Fig. 5 B). This indicates that the extracel-
lular domain of Fas is sufficient to assemble receptor–ligand
clusters. However, the cytosolic domain of Fas might exert a
modulating effect, as at earlier time points cluster formation was
significantly delayed (Fig. 5 B). Notably, Fas
 
 
 
cyt-YFP showed
also an altered dissociation kinetic, as compared with full-length
Fas. When it was clustered with CFP-FasL or CFP-FasL
 
 
 
cyt, a
significant reduction in 
 
t
 
1/2
 
 of 
 
 
 
50% was observed in both cases
(compare Fig. 5 C with Fig. 3). These observations open the pos-
sibility that the cytosolic DISC or homotypic interaction of the
Fas death domain might further stabilize the ligand–receptor in-
teractions, without having an essential role on its initiation. Sim-
ilar as the corresponding full-length counterparts, both fluores-
cent FasL-deletion proteins localized to the plasma membrane.
In contrast to the speckled membrane distribution of YFP-FasL
(Fig. 1 B), FasL
 
 
 
cyt showed a rather homogenous distribution
comparable with Fas receptor fusion proteins. Despite these
slightly different distributions, there were no significant differ-
ences in the mobility of free YFP-FasL
 
 
 
cyt and YFP-FasL in
the membrane of transfected cells. Furthermore, both proteins
showed comparable dissociation kinetics when they were incor-
porated in clusters with Fas-CFP (Fig. 5 C). Together these data
show that the cytoplasmic domains of Fas and FasL, as well as
the associated signaling pathways are dispensable for the forma-
tion of supramolecular FasL-Fas clusters. Furthermore, the cyto-
plasmic domain of Fas, but not FasL, has a modulating effect in
this process. However, it is possible that the somewhat reduced
stability of Fas
 
 
 
cyt-YFP clusters reflects a clustering promoting
effect of Fas signaling or the Fas death domain, which may be-
come relevant when Fas agonists of restricted activity, as anti-
bodies or cross-linked soluble FasL, were used.
 
Lipid rafts and the cytoplasmic domain of 
Fas have a major role in soluble FasL-
induced SPOTS formation, but are 
dispensable for membrane FasL-induced 
Fas cluster formation
 
It has been suggested that constitutive or inducible localization
of Fas in membrane areas enriched in cholesterol and sphin-
golipids (lipid rafts) can be necessary for both clustering and ac-
tivation of Fas by soluble agonists (Grassme et al., 2001a,b;
Hueber et al., 2002; Aouad et al., 2004; Muppidi and Siegel,
2004). Accordingly, Fas signaling was abrogated in various
studies by pretreatment of cells with the cholesterol deplet-
ing compound methyl-
 
 
 
-cyclodextrin (
 
 
 
MCD; Cremesti et al.,
2001; Grassme et al., 2001a,b; Hueber et al., 2002; Muppidi and
Siegel, 2004). This raised the question of whether the induction
of supramolecular Fas clusters by membrane FasL was de-
pendent of lipid rafts. First, we analyzed association of Fas-
YFP and YFP-FasL with lipid rafts in HeLa cells using cell frac-
tionation on sucrose gradients. Transiently expressed lipid raft
marker proteins, such as Lck-GFP and a palmitylated YFP vari-
ant were found as expected in the detergent insoluble factions
obtained in our experiments (Fig. 6 A). In contrast, cytosolic
proteins such as JNK and predominantly cytosolic proteins as
tubulin which are not (JNK) or only barely (tubulin) associated
with lipid rafts were found in the detergent soluble fractions
(Fig. 6 A). Notably, Fas-YFP and YFP-FasL were almost exclu-
sively detected in the detergent insoluble fraction in HeLa cells
indicating a constitutive association with lipid rafts (Fig. 6 A).
This strong association with lipid rafts was also maintained
when both proteins were incorporated in supramolecular clus-
ters. Interestingly, lipid raft association of Fas-YFP was not de-
pendent on its cytoplasmic domain, because the corresponding
Fas deletion mutant was also mainly detected in the detergent
insoluble fractions (Fig. 6 A). The constitutive association of
Fas with lipid rafts was further confirmed by fluorescence mi-
croscopy. HeLa cells expressing Fas-CFP were labeled with
rhodamine-conjugated cholera toxin B to visualize ganglioside
GM1. After patching with an anti–cholera toxin B antibody,
strong colocalization in punctuate structures of Fas and cholera
toxin was observed in the majority of cells (Fig. S3, available at
http://www.jcb.org/cgi/content/full/jcb.200501048/DC1). The
putative requirement of lipid rafts for the formation of FasL-Fas
clusters was then analyzed in cells, which were depleted of cho-
 
Figure 5.
 
Cytoplasmic deletion mutants of FasL and Fas are able to form stable clusters.
 
 (A) Scheme of YFP and CFP fusion proteins of Fas and FasL variants
lacking the cytoplasmic domains. (B) HeLa cells were either transfected with Fas-YFP or Fas
 
 
 
cyt-YFP, grown overnight on cover glasses in 6 well plates and
overlaid by centrifugation with FasL-CFP expressing HEK293 cells. Cells were then cocultured at 37
 
 
 
C and fixed after the indicated time intervals. 90 yellow
fluorescent cells which were in contact with blue fluorescent cells were analyzed for cluster incidence. The portions of Fas-YFP and Fas
 
 
 
cyt-YFP expressing
cells, which formed clusters are indicated. (C) FLIP analysis of free and clustered YFP fusion proteins of FasL and Fas variants lacking the cytoplasmic
domains. HeLa cells were individually transfected with the indicated YFP and CFP fusion proteins and cocultured in the indicated combinations. FLIP exper-
iments were then performed as described in Fig. 3. Again, dotted lines indicate the bleach areas; solid lines, the ROI of clustered or free YFP fusion proteins;
and the dashed lines identify the control ROI. A further control with a cell cotransfected with Fas
 
 
 
cyt and membrane CFP is shown to demonstrate mainte-
nance of the overall morphology of bleached cells during bleaching (top, third row). 
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lesterol by treatment with 
 
 
 
MCD. In these experiments, we pre-
treated Fas-YFP expressing HeLa cells in serum free medium
with 20 mM 
 
 
 
MCD for 20 min at 37
 
 
 
C, added freshly harvested
CFP-FasL expressing cells and followed cluster formation on-
line. Cell fractionation of cholesterol depleted cells on sucrose
gradients confirmed that the vast majority of Fas-YFP or Lck-
GFP had shifted into the detergent soluble fraction (Fig. 6
A). Successful cholesterol depletion was also evident from the
fact that 
 
 
 
MCD-treated cells showed significant morphological
changes. FasL-Fas clusters were still efficiently formed, when
cells expressing the corresponding molecules came into contact,
although the assembly of cluster formation was delayed (Fig. 6,
B and C). Moreover, clusters were even formed and maintained
in cells that were rounded up and detached from the culture dish.
It has been shown in a recent study that cross-linked solu-
ble FasL induce microscopically visible punctuate receptor oli-
gomers in an early stage of Fas-induced apoptosis (Siegel et al.,
2004). These structures were termed SPOTS and are possibly
related to the supramolecular Fas clusters described in our
study. Therefore, we have compared effects of membrane FasL
and cross-linked soluble FasL on Fas-YFP aggregation. Al-
though both FasL forms efficiently triggered Fas aggregation
(SPOTS or clusters, respectively), some notable differences
were also observed. In accordance with the data reported by
Siegel et al. (2004), we found that soluble FasL was crucially
dependent on the cytoplasmic domain of Fas to induce the for-
mation of SPOTS (Fig. 7, A and B). In contrast, as already
shown in Fig. 5, deletion of the cytoplasmic domain of Fas
only caused a delay in the kinetics of membrane FasL-induced
cluster formation. Furthermore, Fas-YFP SPOTS formation by
soluble FasL was completely abrogated in cholesterol depleted
cells, whereas membrane FasL-induced cluster formation was
only delayed (Fig. 6 B and Fig. 7 A).
 
Discussion
 
In previous reports the events of Fas activation have been stud-
ied using Fas-specific antibodies, cross-linked soluble FasL
(sFasL) or chimeric FasL fusion proteins. However, the physio-
logic activator of Fas in vivo is membrane FasL. There is further
evidence that membrane FasL, soluble FasL, and anti-Fas anti-
bodies do not use exactly the same mechanisms to activate Fas.
 
Figure 6.
 
Fas-YFP and CFP-FasL are constitutively associated with lipid
rafts.
 
 (A) HeLa cells were transiently transfected with the indicated fusion
proteins and were grown individually or as cocultures. The next day, cells
were analyzed by cell fractionation on sucrose gradients as described in
Materials and methods. Four fractions were obtained which are shown here
from top (1) to bottom (4). Fraction 1, the top fraction corresponded to the
lowest sucrose density. This detergent insoluble fraction contained micro-
domains and lipid rafts. Fraction 4 contained the vast majority of total pro-
tein and represented the detergent soluble fraction. The detected proteins
and the antibodies used in Western blot analysis are indicated. In experi-
ments shown on the bottom panel, cells had been treated (
 
 
 
) or not (
 
 
 
) with
the cholesterol depleting drug 
 
 
 
MCD for 20 min before fractionation in or-
der to resolve lipid rafts. (B) HeLa cells expressing Fas-YFP were treated with
 
 
 
MCD for 20 min (gray bars) or left untreated (black bars) and then over-
laid with CFP-FasL expressing HEK293 cells by centrifugation. Cells were
fixed after the indicated time intervals and the cluster incidence of neighbor-
ing cell pairs expressing Fas-YFP and CFP-FasL was determined as de-
scribed in Materials and methods. The experiment was done in triplicates.
(C) HeLa cells were transfected with CFP-FasL and Fas-YFP and grown sepa-
rately. The next day, Fas-YFP transfectants were depleted for cholesterol
(20 mM 
 
 
 
MCD, 20 min) in serum-free medium and cocultured with CFP-FasL
expressing cells. Online imaging was started when cells came into contact. 
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For example, earlier studies have found that anti-Fas antibody-
induced Fas activation correlates with the formation of SDS-sta-
ble Fas microaggregates. It was proposed that this event is a cru-
cial step preceding DISC assembly and Fas signaling (Kischkel
et al., 1995; Kamitani et al., 1997; Ruiz-Ruiz et al., 1999;
Varadhachary et al., 2001; Algeciras-Schimnich et al., 2002).
However, a recent report challenged the main functional rele-
vance of the SDS-stable Fas microaggregates by the observation
that these aggregates only occur in antibody-induced Fas activa-
tion, but not when Fas activation was achieved by a multimeric
FasL fusion protein (Legembre et al., 2003). Moreover, another
study found that the serine protease inhibitor TLCK does reduce
formation of SDS-stable Fas microaggregates, but nevertheless
enhances Fas-induced caspase-8 activation (Lee and Shacter,
2001). It is currently also unclear whether membrane FasL,
cross-linked sFasL and anti-Fas antibodies induce Fas clustering
in a similar fashion. In particular, some studies reported that Fas
clustering induced by cross-linked sFasL or anti-Fas antibodies
is a delayed event occurring in an actin- and caspase-dependent,
but lipid raft–independent manner (Algeciras-Schimnich et al.,
2002), whereas other reports found rapid Fas capping under in-
volvement of lipid rafts (Cremesti et al., 2001; Grassme et al.,
2001a,b). Remarkably, in all these studies, Fas capping/cluster-
ing is the consequence of active Fas signaling and initial DISC
formation and in so far seems to reflect a positive feedback loop
of Fas activated signals on Fas cluster formation.
Using fluorescent fusion proteins of FasL and Fas we de-
scribe here that membrane FasL, induces efficient receptor clus-
tering similar to cross-linked sFasL and anti-Fas antibodies. This
suggests that the formation of higher order complexes of Fas and
FasL is an essential step in membrane FasL-induced Fas activa-
tion. Time lapse microscopy and fluorescence loss in pho-
tobleaching (FLIP) in living cells revealed that membrane FasL-
Fas clusters formed between neighboring cells expressing
membrane CFP-FasL and Fas-YFP, respectively, are highly sta-
ble and enduring over a period of several hours, Moreover, there
was no evidence for internalization of Fas-FasL clusters formed
after cell–cell contact (Fig. 2). This is an interesting difference from
Fas activation with soluble reagents, where internalization has
been observed (Algeciras-Schimnich et al., 2002; Eramo et al.,
2004). Therefore, it appears possible that Fas internalization is
not a major consequence of Fas activation but rather an effect re-
lated to soluble agonists. Moreover, membrane FasL-induced
Fas cluster formation at the cell membrane resulted in gene in-
Figure 7. Induction of Fas SPOTS by soluble cross-linked FasL depends on the cytoplasmic domain of Fas and association with lipid rafts. (A, left) HeLa
cells were transfected with Fas-YFP, Fas cyt-YFP, or membrane-YFP and stimulated 18 h after transfection with the indicated combinations of cross-linked
soluble Flag-FasL (200 ng/ml) and z-VAD-fmk (20  M). The proportion of cells that showed SPOTS was determined after 2 h. (Middle) HeLa cells expressing
either Fas-YFP (black bars) or Fas cyt-YFP (gray bars) were cocultured with HEK293 cells, transiently transfected with CFP-FasL. After 1 h of coculture,
neighbored blue and yellow fluorescent cells were analyzed and cluster incidence was determined as described in Materials and methods. (Right) HeLa
cells expressing Fas-YFP were treated for 20 min with 20 mM  MCD, stimulated for with M2-Flag cross-linked soluble Flag-FasL (200 ng/ml), or cocultured with
CFP-FasL expressing HEK293 cells. SPOTS incidence and cluster incidence were determined after 1 h. (B) Microscopic images of cells expressing Fas-YFP or
Fas cyt-YFP before (0 h) and after stimulation with the indicated reagents (2 h). The image showing Flag-FasL/M2 challenged cells was already taken after 1 h. 
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duction or was followed by rapid cell death in the absence of the
caspase inhibitor zVAD-fmk (Fig. 7 B; Fig. S1). Thus, our data
demonstrate that proper Fas signaling is initiated at the mem-
brane and does not require internalization. The latter may only
becomes relevant when clusters were formed between membrane
FasL and Fas, expressed in the same cell or when cluster-bound
membrane FasL is shed. The long persistence of membrane
FasL-Fas clusters could be of special relevance when FasL ex-
pressing cells stimulate apoptosis in resistant Fas expressing cells
that can however become sensitive by regulatory mechanisms.
Membrane FasL-induced higher order complexes with
Fas were also formed when Fas was expressed in FADD- or
caspase-8–deficient cells, in the presence of a broad range cas-
pase inhibitor and when a cytoplasmic Fas deletion mutant was
used. Thus, cluster formation occurred under circumstances,
where activation of the currently known Fas-induced signaling
pathways, in particular caspase-8 activation, was blocked. The
concept that Fas induced caspase-8 activation is not an obligate
step in robust Fas activation is also in agreement with the signal-
ing capabilities of mutated Fas in lpr-cg mice (Desbarats et al.,
2003). These mice show normal Fas-induced ERK activation
despite a mutation in the death domain of Fas which prevents
caspase-8 activation and apoptosis induction. Moreover, an in-
dependent Fas deletion mutant has been described, which inter-
feres with FADD binding and apoptosis induction but still has
the capacity to trigger JNK activation (Chang et al., 1999).
The relevance of lipid rafts, distinct plasma membrane mi-
crodomains enriched in cholesterol and sphingolipids, for Fas-
induced DISC formation has been intensively studied. Although
some studies found Fas constitutively outside of lipid rafts (Ko
et al., 1999; Algeciras-Schimnich et al., 2002, Legler et al.,
2003), other reports described significant incorporation of Fas
and the DISC components caspase-8 and FADD in such mem-
brane areas constitutively or after stimulation (Grassme et al.,
2001a,b; Hueber et al., 2002; Aouad et al., 2004). These discrep-
ancies have been partly attributed to different roles of lipid rafts
for Fas signaling in type I and type II cells and may also depend
on regulatory events not causally linked to Fas activation. For
example, it has been recently shown that TCR signaling in acti-
vated CD4
 
 
 
 T cells induces relocation of Fas into lipid rafts
(Muppidi and Siegel, 2004). Due to the complex and presumably
cell type specific role of lipid rafts in Fas activation, we have
clarified here the relationship between lipid rafts and the for-
mation of membrane FasL-induced Fas clusters. We found that
both Fas-YFP and YFP-FasL were constitutively associated with
lipid rafts in HeLa cells (Fig. 6 A). This finding is in agreement
with a previous report by Hueber et al. (2002), showing a com-
parable constitutive raft association of Fas in thymus cells. How-
ever, HeLa cells were strongly protected by Bcl2 overexpression
against Fas-induced apoptosis (Mandal et al., 1996; unpublished
data) and are therefore type II cells, whereas thymocytes are type
I cells. Thus, constitutive raft association of Fas does not neces-
sarily correlate with grouping cells into type I and type II. Note-
worthy, Fas-YFP remained in association with lipid rafts when it
was incorporated into membrane FasL-induced clusters (Fig. 6
A). In our experiments, lipid raft association of Fas did not cru-
cially depend on its cytoplasmic domain suggesting that the Fas
lipid raft association is not related to receptor activation in
HeLa cells. The lipid raft association of Fas was not necessary
for membrane FasL-induced cluster formation and showed
only a modulating effect on this process (Fig. 6 B). In contrast
to membrane FasL, cross-linked soluble FasL failed to induce
SPOTS after dislocation of Fas from lipid rafts (Fig. 7). More-
over, SPOTS formation was also dependent on an intact cyto-
plasmic Fas domain (Fig. 7). SPOTS induced by soluble FasL
and supramolecular clusters induced by membrane FasL are
both activation-associated structures composed of Fas aggre-
gates and are possibly formed by related mechanisms. How-
ever, due to the differential relevance of lipid raft association
and the cytoplasmic domain of Fas for SPOTS and cluster for-
mation, some differences must exist for the formation of these
structures. Based on the experiments with the Fas
 
 
 
cyt mutants,
it appears that Fas associated signaling events have a crucial
role in Fas aggregation during SPOTS formation, but are not
essential for Fas aggregation in membrane FasL-induced clus-
ter formation. In fact, as already discussed above, it has been
shown that initial Fas-mediated caspase-8 activation is neces-
sary to trigger a positive feedback loop ensuring robust Fas sig-
naling after stimulation with soluble FasL (or agonistic Fas an-
tibodies; Grassme et al., 2001b; Algeciras-Schimnich et al.,
2002). This gives rise to the question of why these Fas signal-
ing dependent mechanisms are less important in membrane
FasL-induced cluster formation and Fas activation. Perhaps,
the spatial orientation and mobility reduction of membrane
FasL in the plasma membrane facilitates Fas aggregation, mak-
ing cytosolic events dispensable for membrane FasL-induced
Fas clustering. The absence of Fas signaling may therefore
only result in the observed delay in cluster formation. In con-
trast, it is tempting to speculate that in case of soluble FasL,
the signaling dependent mechanisms of Fas aggregation gain
higher relevance or are even essential, as cross-linked soluble
FasL can possibly not fully substitute for plasma membrane or-
ganized FasL molecules. A similar argumentation may also ex-
plain the differential relevance of lipid rafts in membrane
FasL-induced Fas clustering and soluble FasL-induced SPOTS
formation. However, as first Fas resides constitutively in lipid
rafts, also in unstimulated cells, and second Fas
 
 
 
cyt-YFP is
still raft associated, enhancement of Fas aggregation by initial
Fas signaling is most likely not related to association of Fas
with lipid rafts. Thus, lipid raft association of Fas and a posi-
tive feedback of events associated with the Fas cytoplasmic
domain may represent two independent mechanisms, com-
pensating for the missing plasma membrane enforced spatial
orientation of FasL when its soluble variant is used for Fas
activation.
 
Materials and methods
 
Reagents, plasmids, and cell lines
 
cDNAs corresponding to full-length Fas or a deletion mutant containing the
extracellular domain and transmembrane domain of Fas were generated
by PCR with the expression construct pEF-Bos-Fas as template, using the
primers Fas-F, Fas-R and Fas
 
 
 
cyt-R with introduce EcoR1 and Sac2 sites
(Fas-F: 5
 
 
 
-CCG 
 
GAA TTC
 
 ACA ACC ATG CTG GGC ATC TGG ACC-3
 
 
 
;
Fas-R: 5
 
 
 
-TCC 
 
CCG CGG
 
 GAC CAA GCT TTG GAT TTC ATT TCT G-3
 
 
 
;
Fas
 
 
 
cyt-R: 5
 
 
 
-TCC 
 
CCG CGG
 
 CTT TCT CTT CAC CCA AAC AAT TAG-3
 
 
 
). 
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The amplicons were inserted into the corresponding sites of pEYFP-N1 and
pECFP-N1 (CLONTECH Laboratories, Inc.). Similarly, cDNAs encoding
full-length FasL or a cytoplasmic deletion mutant of FasL were derived from
pcDNA3-FasL by PCR using the primers FasL-F, FasL-R, and FasL
 
 
 
cyt-F con-
taining EcoR1 and BamH1 sites (FasL-F: 5
 
 
 
-GCT TC
 
G AAT TC
 
T ATG CAG
CAG CCC TTC AAT TAC CCA-3
 
 
 
; FasL
 
 
 
cyt-F: 5
 
 
 
-CCG TC
 
G AAT TC
 
T GGC
CTG TGT CTC CTT GTG ATG TTT TTC-3
 
 
 
 FasL-R: 5
 
 
 
-CAC GCC GGC 
 
GGA
TCC GTG CTT CTC TTA GAG CTT ATA TAA GCC G-3 ). The amplicons
were inserted into the corresponding sites of pEYFP-C1 and pECFP-C1.
pEF-Bos-Fas and pcDNA3-FasL were provided by H. Engelmann (Munich
University, Munich, Germany). HeLa, HT1080 and HEK293 cells were ob-
tained from ATCC and NCTC cells were a gift from W.S. Wels (Chemo-
therapeutisches Forschungsinstitut Georg-Speyer-Haus, Frankfurt am Main,
Germany). The Jurkat T cell lines deficient for FADD and caspase-8 expres-
sion and the corresponding parental control cell line were a gift from P.
Juo and J. Blenis (Harvard Medical School, Boston, MA) and are de-
scribed elsewhere (Juo et al., 1998, 1999). The expression plasmid en-
coding palmitylated CFP was a gift from R.Y. Tsien (Howard Hughes Med-
ical Institute, San Diego, CA). All cells were cultured in DME (GIBCO BRL)
supplemented with 5% FCS and grown in 5% CO2 at 37 C.
Determination of Fas-mediated apoptosis
Cells transfected with the indicated expression plasmids were cultured
overnight. The next day, 2.5  g/ml CHX was added and after 10 h, cell
death was analyzed by crystal violet staining. Alternatively, Fas-YFP ex-
pressing cells were stimulated with cross-linked soluble Fas for 2 h. In
these experiments, apoptotic effects were analyzed mircoscopically. Cells
that rounded up and/or detached from the cover slide were defined as dy-
ing cell. Dying and normal cells were counted to determine the viability of
Fas-YFP expressing cells.
Microscopic analysis of living cells or fixed samples
An inverted confocal microscope (model DM IRBE; Leica) with a 63  objec-
tive (HCX PL APO 63 /1.32 oil) was used for online analysis of living
cells. The microscope carried a preconditioned chamber (37 C, 5% CO2)
on its stage and was operated by confocal software TCS SL (v. 2.5.1227,
serial no. 194043; Leica). Living cells were grown on glass bottom culture
dishes, observed over 20 min up to several hours and imaged in regular in-
tervals. Fixed and mounted cells were analyzed using a DM RE confocal mi-
croscope with a 100  objective (HCX PL APO 100 /1.40 oil; Leica). This
microscope was operated by confocal software TCS SP2 (v. 2.5.1227;
Leica). In all microscopic experiments excitation of CFP fusion proteins was
performed at 456 nm, the emission was detected between 470 and 500
nm and visualized blue. Excitation of YFP proteins was done at 514 nm, the
emission signal was detected above 600 nm and visualized yellow. Analy-
sis of fluorescent samples, containing both CFP and YFP proteins were done
by sequential screening. The absence of nonspecific signals in both se-
lected emission ranges was verified. Overlays of different staining patterns
in living cells were directly obtained as snapshots from Leica experimental
files. Photographs of fixed cells, showing CFP/YFP costaining were derived
by overlay of individual images in Adobe photoshop version 7.0.
FLIP analysis
These experiments were performed using cocultures of HeLa cells that ex-
pressed complementary YFP/CFP variants of Fas and FasL. Neighboring
cells showing suitable receptor–ligand aggregates were analyzed. In all
photo-bleaching experiments the excitation was performed at 514 nm
(YFP channel) and the laser energy was constantly maintained at 80% of
maximum. The bleached area included most of the cell that expressed the
YFP-tagged fusion protein, but excluded receptor–ligand clusters or a
small part of the plasma membrane. The analysis took further advantage
of the time lapse function, provided by the Leica confocal software. Cells
were sequentially imaged in both YFP and CFP channels in 1-min time in-
tervals. Between these times, a maximal excitation applied to the selected
bleached areas. Images of each experiment were merged into a single
Leica experimental series, as recommended in the software manual. This fa-
cilitated the determination of fluorescence intensities in corresponding sec-
tions of all merged images. Receptor–ligand clusters, plasma membrane
areas and control regions were selected as region of interests (ROIs) and
ROI fluorescence was quantified, using an integrated function of the Leica
Confocal Software. Importantly, we have manually verified that the se-
lected ROIs corresponded in all cases to the analyzed structures in each
single image, because we did occasionally observe movements of the
cells or the microscopic stage. The cluster specific YFP fluorescence was
obtained by correction for the fluorescence of the corresponding “free”
compound in a comparable ROI. Dependent on the morphology of the
clusters and the shape of the ROIs fluorescence of “free” YFP-FasL or Fas-
YFP was between 50 and 80% of the fluorescence of the clustered mole-
cules. However, after five bleach cycles the fluorescence intensities of the
nonclustered fusion proteins outside the bleach region was regularly be-
low 5% of the fluorescence of clustered molecules. This time point was
therefore defined as t   0. In FLIP experiments with nonclustered Fas-YFP
and YFP-FasL, the corresponding fluorescence was corrected for the
bleach dynamics in the bleach region itself. The corrected fluorescence in-
tensities were normalized against the corrected relative fluorescence inten-
sity obtained after the initial 5 min. Normalized relative fluorescence in-
tensities of corresponding time points of 12–15 FLIP experiments were
averaged and plotted over time. To calculate the time (t1/2) when 50% of
the fluorescence of the YFP fusion proteins was bleached, the curves ob-
tained were linearized by plotting the natural logarithm of the relative fluo-
rescence intensities over time.
Determination of FasL-Fas cluster incidence
5   10
6 HeLa cells were transfected with 20  g of plasmid DNA encod-
ing Fas-YFP or Fas cyt-YFP by electroporation and cultured in 6 well
plates, containing one 18   18 cm glass cover slide per well. In parallel,
2   10
7 HEK293 cells were transiently transfected with CFP-FasL and cul-
tured overnight. The next day, the medium was removed from the 6 well
plates and 2 ml of a 4 C cold cell suspension, containing 2   10
6 trans-
fected HEK293 cells was added into each well. Plates were centrifuged at
1,200 rpm for 5 min at 4 C and the cover glasses were then incubated at
37 C for the indicated times. Cells were fixed and investigated by fluores-
cence microscopy. A field of  150   150  m of was randomly selected.
All Fas-YFP or Fas cyt-YFP expressing cells found within this field were an-
alyzed of whether they were in contact with one or more CFP-FasL express-
ing HEK293 cell. Isolated Fas-YFP or Fas cyt-YFP expressing HeLa cells
that were not neighbored or overlaid by CFP-FasL expressing HEK293
cells were excluded from further analysis. Fas-YFP or Fas cyt-YFP express-
ing HeLa cells that were in apparent contact with CFP-FasL transfected
cells were investigated for cluster formation. Clusters were defined by their
spot-like or aggregated morphology, as well as by strong codetection of
blue and yellow fluorescence. This analysis was continued in equivalent
fields until 100 cell pairs were analyzed. The percentage of cell pairs with
clusters of Fas-YFP/Fas cyt-YFP and CFP-FasL are indicated. Cluster inci-
dence of Fas-YFP in Jurkat cells was determined by online fluorescence mi-
croscopy. HeLa cells expressing CFP-FasL were cultured in Matek glass
bottom dishes and overlaid with 5 x10
6 cells of the indicated Jurkat cell
line, which had been transfected with 50  g Fas-YFP cells by electropora-
tion. After 3 h, all Fas-YFP expressing cells in the dish which were in ap-
parent contact with CFP-FasL expressing HeLa cells were investigated for
cluster formation and the cluster incidence was calculated.
Preparation of detergent insoluble raft membrane microdomain fractions
5   10
7 cells, expressing the proteins of interest were harvested with a
rubber policemen, pelleted, resuspended in 200  l serum free RPMI me-
dium, and kept on ice. Cells were then lysed in 200  l ice-cold Brij-96 lysis
buffer [0.1% Brij-96 in TNE (25 mM Tris, pH 7.5, 150 mM NaCl, 5 mM
EDTA, 1 mM Pefabloc, 5 mM iodoacetamide; 1 mM Na3VO4,1 mM
NaF)]. The lysates were mixed with 80% sucrose in TNE buffer, transferred
into an ultra centrifugation tube and overlaid with 2.8 ml 30% sucrose in
TNE, followed by 400  l TNE. Samples were centrifuged at 50,000 rpm
in a TST 60.4 rotor (Sorvall) for 22 h at 4 C. Proteins in the four collected
fractions were precipitated by addition of 1.5 ml ice-cold acetone. Pre-
cipitates were resolved in SDS sample buffer and analyzed by Western
blotting, using the following antibodies: anti-GFP (mAb; Roche); anti-JNK
(rabbit pAb; Cell Signaling) and anti-tubulin (NeoMarkers). Based on local-
ization of Lck-GFP (Janes et al., 1999) and palmitylated YFP (Zacharias et
al., 2002) the top fraction (1) was identified as detergent insoluble raft
membrane microdomain fraction. The bottom fraction (4), which contained
the vast majority of total protein was correspondingly identified as deter-
gent soluble. To dissolve lipid rafts, cells were treated with 20 mM of the
cholesterol-depleting drug  MCD in serum-free medium at 37 C for 20
min. Cells were then harvested for analysis or analyzed further by online
fluorescence microscopy (37 C, 5% CO2) for up to one more hour.
FACS analysis
To analyze the effects of FasL stimulation on Fas cell surface expression Fas
overexpressing HeLa cells were challenged with anti-Flag mAb M2 (1  g/
ml) cross-linked soluble Flag-FasL (400 ng/ml) for 1 h on ice or at 37 C and
analyzed afterwards by FACS. For this purpose cells were stained with anti–
Fas-FITC mAb FAB128 (R&D Systems) which does not compete with Flag-
FasL for Fas binding for 1 h on ice. To avoid interference of protein resynthe-JCB • VOLUME 168 • NUMBER 7 • 2005 1098
sis 25  g/ml CHX was added 30 min before stimulation. Finally cells were
analyzed by FACS.
Online supplemental material
Figs. S1 and S2 show that a YFP/CFP tag does not interfere with the func-
tional properties of Fas, FasL, Fas cyt and FasL cyt. Fig. S3 shows colo-
calization of Fas-CFP and cholera toxin B–rhodamine in anti–cholera toxin
B patched cells. Online supplemental material is available at http://
www.jcb.org/cgi/content/full/jcb.200501048/DC1.
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